• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒既往感染和 mRNA 疫苗接种对传染性和易感性的影响。

Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection.

机构信息

Faculty of Medicine, University of Geneva, Geneva, Switzerland.

General internal medicine division, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.

出版信息

Nat Commun. 2023 Sep 6;14(1):5452. doi: 10.1038/s41467-023-41109-9.

DOI:10.1038/s41467-023-41109-9
PMID:37673865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10482859/
Abstract

The immunity conferred by SARS-CoV-2 vaccines and infections reduces the transmission of the virus. To answer how the effect of immunity is shared between a reduction of infectiousness and an increased protection against infection, we examined >50,000 positive cases and >110,000 contacts from Geneva, Switzerland (June 2020 to March 2022). We assessed the association between secondary attack rate (i.e. proportion of new cases among contacts) and immunity from natural infection and/or vaccination, stratifying per four SARS-CoV-2 variants and adjusting for index cases and contacts' socio-demographic characteristics and the propensity of the contacts to be tested. Here we show that immunity protected contacts from infection, rather than reducing infectiousness of index cases. Natural infection conferred the strongest immunity. Hybrid immunity did not surpass recent infection. Although of smaller amplitude, the reduction in infectiousness due to vaccination was less affected by time and by the emergence of new SARS-CoV-2 variants than the susceptibility to infection. These findings support the role of vaccine in reducing infectiousness and underscore the complementary role of interventions reducing SARS-CoV-2 propagation, such as mask use or indoor ventilation.

摘要

SARS-CoV-2 疫苗和感染提供的免疫力降低了病毒的传播。为了回答免疫力对传染性降低和对感染的保护增强的作用如何共享,我们研究了来自瑞士日内瓦的超过 50000 例阳性病例和超过 110000 名接触者(2020 年 6 月至 2022 年 3 月)。我们评估了二次攻击率(即接触者中新病例的比例)与自然感染和/或疫苗接种的免疫力之间的关联,按 SARS-CoV-2 的四个变体分层,并调整了索引病例和接触者的社会人口特征以及接触者接受检测的倾向。在这里,我们表明免疫力保护接触者免受感染,而不是降低索引病例的传染性。自然感染提供了最强的免疫力。混合免疫力并未超过近期感染。尽管幅度较小,但由于疫苗接种而导致的传染性降低不太受时间和新 SARS-CoV-2 变体出现的影响,而对感染的易感性则受到影响。这些发现支持疫苗在降低传染性方面的作用,并强调了减少 SARS-CoV-2 传播的干预措施(如戴口罩或室内通风)的互补作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1863/10482859/a1dafe4fdf93/41467_2023_41109_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1863/10482859/fa1484d3eb3d/41467_2023_41109_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1863/10482859/a1dafe4fdf93/41467_2023_41109_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1863/10482859/fa1484d3eb3d/41467_2023_41109_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1863/10482859/a1dafe4fdf93/41467_2023_41109_Fig2_HTML.jpg

相似文献

1
Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection.新冠病毒既往感染和 mRNA 疫苗接种对传染性和易感性的影响。
Nat Commun. 2023 Sep 6;14(1):5452. doi: 10.1038/s41467-023-41109-9.
2
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
3
Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study.COVID-19 疫苗接种对社交和家庭密切接触者中 SARS-CoV-2 传播的影响:一项队列研究。
J Infect Public Health. 2023 Mar;16(3):410-417. doi: 10.1016/j.jiph.2023.01.017. Epub 2023 Jan 25.
4
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
5
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.医护人员中,mRNA 疫苗接种与未接种者,初次感染奥密克戎(B.1.1.529)BA.1 或 前奥密克戎 SARS-CoV-2 对 BA.2 再感染的保护作用:一项病例对照研究。
Lancet Infect Dis. 2023 Jan;23(1):45-55. doi: 10.1016/S1473-3099(22)00578-3. Epub 2022 Sep 21.
6
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.阿尔法(B.1.1.7)和德尔塔(B.1.617.2)变异株之间的传播差异。
Microbiol Spectr. 2022 Apr 27;10(2):e0000822. doi: 10.1128/spectrum.00008-22. Epub 2022 Apr 12.
7
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
8
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.在以色列,接种BNT162b2疫苗可减少新冠病毒向家庭接触者的传播。
medRxiv. 2021 Dec 20:2021.07.13.21260393. doi: 10.1101/2021.07.13.21260393.
9
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections.SARS-CoV-2 阿尔法、贝塔和德尔塔变异株、年龄、疫苗接种和既往感染对 SARS-CoV-2 感染传染性的影响。
Front Immunol. 2022 Sep 13;13:984784. doi: 10.3389/fimmu.2022.984784. eCollection 2022.
10
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.2021 年 1 月至 4 月,在 Alpha 变异株流行期间,接种疫苗和未接种疫苗的家庭接触者中的 SARS-CoV-2 感染风险 - 科罗拉多州丹佛市和加利福尼亚州圣地亚哥市。
Vaccine. 2022 Aug 5;40(33):4845-4855. doi: 10.1016/j.vaccine.2022.06.066. Epub 2022 Jul 4.

引用本文的文献

1
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.既往感染过严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的5至17岁个体的疫苗有效性:一项基于电子健康记录(EHR)的目标试验模拟研究,来自RECOVER项目。
Res Sq. 2025 Jul 3:rs.3.rs-6945998. doi: 10.21203/rs.3.rs-6945998/v1.
2
The immunological impact of revaccination in a hybrid-immune world.在混合免疫的世界中再次接种疫苗的免疫学影响。
Front Immunol. 2025 Jun 9;16:1588259. doi: 10.3389/fimmu.2025.1588259. eCollection 2025.
3
Mucosal boosting increases protective efficacy of an influenza vaccine in mice.

本文引用的文献

1
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.奥密克戎变异株流行期间 SARS-CoV-2 突破性感染和再感染的传染性。
Nat Med. 2023 Feb;29(2):358-365. doi: 10.1038/s41591-022-02138-x. Epub 2023 Jan 2.
2
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.瑞士日内瓦奥密克戎BA.2浪潮后抗SARS-CoV-2抗体的血清流行率和交叉变异中和能力:一项基于人群的研究
Lancet Reg Health Eur. 2023 Jan;24:100547. doi: 10.1016/j.lanepe.2022.100547. Epub 2022 Dec 1.
3
Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
黏膜加强免疫可提高流感疫苗对小鼠的保护效力。
iScience. 2025 May 21;28(6):112721. doi: 10.1016/j.isci.2025.112721. eCollection 2025 Jun 20.
4
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2.基于下一代腺病毒载体的严重急性呼吸综合征冠状病毒2疫苗
Vaccines (Basel). 2025 Apr 14;13(4):406. doi: 10.3390/vaccines13040406.
5
Nanoparticles of natural product-derived medicines: Beyond the pandemic.天然产物衍生药物的纳米颗粒:疫情之后
Heliyon. 2025 Feb 19;11(4):e42739. doi: 10.1016/j.heliyon.2025.e42739. eCollection 2025 Feb 28.
6
Pathogen priming alters host transmission potential and predictors of transmissibility in a wild songbird species.病原体预激发改变了野生鸣禽物种的宿主传播潜力和传播性预测指标。
mSphere. 2025 Apr 29;10(4):e0088624. doi: 10.1128/msphere.00886-24. Epub 2025 Mar 10.
7
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.既往感染过严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的5至17岁个体的疫苗有效性:一项基于电子健康记录的RECOVER项目目标试验模拟研究。
medRxiv. 2025 Feb 8:2025.02.07.25321814. doi: 10.1101/2025.02.07.25321814.
8
Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O).以基于单一融合蛋白(W-PreS-O)的嵌合疫苗为代表的基于融合蛋白的新冠疫苗。
Front Immunol. 2025 Jan 28;16:1452814. doi: 10.3389/fimmu.2025.1452814. eCollection 2025.
9
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus.基于水疱性口炎病毒(VSV)的复制缺陷型疫苗可引发针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和流感病毒的保护性反应。
Sci Adv. 2025 Jan 31;11(5):eadq4545. doi: 10.1126/sciadv.adq4545. Epub 2025 Jan 29.
10
Agile, on-demand wastewater surveillance of virus infections to support pandemic and outbreak response in Rotterdam-Rijnmond, the Netherlands, 2020 to 2022.2020 年至 2022 年期间,在荷兰鹿特丹-莱茵河畔,采用敏捷、按需的废水病毒感染监测方法,以支持大流行和疫情应对。
Euro Surveill. 2024 Nov;29(47). doi: 10.2807/1560-7917.ES.2024.29.47.2400055.
与 SARS-CoV-2 再感染相关的急性和后期后遗症。
Nat Med. 2022 Nov;28(11):2398-2405. doi: 10.1038/s41591-022-02051-3. Epub 2022 Nov 10.
4
Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff.在学校取消普遍戴口罩措施 - 学生和教职员工的新冠发病率。
N Engl J Med. 2022 Nov 24;387(21):1935-1946. doi: 10.1056/NEJMoa2211029. Epub 2022 Nov 9.
5
Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection.接种多剂疫苗和既往感染后 SARS-CoV-2 德尔塔和奥密克戎变异株的病毒载量动态。
Nat Commun. 2022 Nov 7;13(1):6706. doi: 10.1038/s41467-022-33096-0.
6
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.估计 2020 年和 2021 年有症状 COVID-19 后持续性疲劳、认知和呼吸症状群个体在全球的比例。
JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
7
Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland.SARS-CoV-2 感染的社会经济决定因素:瑞士日内瓦基于人群的横断面血清学调查结果。
Front Public Health. 2022 Sep 23;10:874252. doi: 10.3389/fpubh.2022.874252. eCollection 2022.
8
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study.新冠病毒疫苗对奥密克戎和德尔塔毒株导致住院治疗的有效性:一项检测呈阴性的病例对照研究
Nat Commun. 2022 Sep 30;13(1):5736. doi: 10.1038/s41467-022-33378-7.
9
Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants.与德尔塔变异株相比,SARS-CoV-2 奥密克戎变异株的家庭传播增加和免疫逃逸增强。
Nat Commun. 2022 Sep 29;13(1):5706. doi: 10.1038/s41467-022-33233-9.
10
Household transmission of the SARS-CoV-2 Omicron variant in Denmark.丹麦的 SARS-CoV-2 奥密克戎变异株的家庭传播。
Nat Commun. 2022 Sep 23;13(1):5573. doi: 10.1038/s41467-022-33328-3.